| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.6 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |